Search results
Results from the WOW.Com Content Network
Drug and precursor laws United Nations INCB – Single Convention on Narcotic Drugs, 1961 [1] INCB – Convention on Psychotropic Substances, 1971 [2] INCB – United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances, 1988 [3] INCB "Green list" – List of Psychotropic Substances under International ...
European law on illicit drug precursors: Regulation (EC) No 273/2004 of the European Parliament and of the Council of 11 February 2004 on drug precursors (contains list of substances) Council Regulation (EC) No 111/2005 of 22 December 2004 laying down rules for the monitoring of trade between the Union and third countries in drug precursors.
Adopted legislation - Decisions to ban new psychoactive substances European Commission; Substances and classifications table (31/10/2008) – European Legal Database on Drugs report on all substances controlled in at least one EU country as of 31 October 2008 in XLS format Archived 25 February 2021 at the Wayback Machine
Many drugs have more than one name and, therefore, the same drug may be listed more than once. Brand names and generic names are differentiated by capitalizing brand names. See also the list of the top 100 bestselling branded drugs, ranked by sales. Abbreviations are used in the list as follows: INN = International nonproprietary name
This list is not limited to drugs that were ever approved by the FDA. Some of them (lumiracoxib, rimonabant, tolrestat, ximelagatran and ximelidine, for example) were approved to be marketed in Europe but had not yet been approved for marketing in the US, when side effects became clear and their developers pulled them from the market.
The PUMA process was established to make it more profitable for pharmaceutical companies to market drugs for children. For this purpose, new data used for PUMA approved drugs are protected for 10 years, and the applications are partially exempt from fees. [1] In September 2011, the first drug was approved under this process.
A U.S. appeals court revived a lawsuit on Friday by healthcare and drug industry groups challenging the first-ever U.S. law requiring pharmaceutical companies to negotiate drug prices with the ...
Drug Master File (DMF) is a document containing complete information on an Active Pharmaceutical Ingredient (API) or finished drug dosage form.It is known as European Drug Master File (EDMF) or Active Substance Master File (ASMF) and US-Drug Master file (US-DMF) in Europe and United States respectively.